Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke - a randomized, double-blind, placebo-controlled trial

Acta Neurologica Scandinavica

Volumn 123, Issue 4, 2011, Pages 266-273

  Lokk, J ^a   Roghani, R Salman ^b   Delbari, A ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Functional recovery; Levodopa; Methylphenidate; Motor recovery; Physiotherapy; Stroke

Indexed keywords

LEVODOPA; METHYLPHENIDATE; PLACEBO;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CONVALESCENCE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NAUSEA; NERVOUSNESS; PHYSIOTHERAPY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STROKE; VOMITING;

ACTIVITIES OF DAILY LIVING; AGED; CENTRAL NERVOUS SYSTEM STIMULANTS; COMBINED MODALITY THERAPY; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEVODOPA; MALE; METHYLPHENIDATE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; RECOVERY OF FUNCTION; STROKE;

EID: 79952085791     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01395.x     Document Type: Article

References (47)

1. Gladstone D, Black S. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci 2000;27:97-105.
2. Broeks J, Lankhorst G, Rumping K, Prevo A. The long-term outcome of arm function after stroke: results of a follow-up study. Disabil Rehabil 1999;21:357-64.
3. Paolucci S, De Angelis D. New developments on drug treatment rehabilitation. Clin Exp Hypertens 2006;28:345-8.
4. Losseff N. Neurological rehabilitation of stroke. London: Informa Healthcare 2004; 10.
5. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke: further evidence. Stroke 1995;26:225-9.
6. Pariente J, Loubinoux I, Carel C et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001;50:718-29.
7. Berthier M, Pujol J, Gironell A et al. Beneficial effect of donepezil on sensorimotor function after stroke. Am J Phys Med Rehabil 2003;82:725-9.
8. Scheidtmann K, Fries W, Müller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001;358:787-90.
9. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998;79:1047-50.
10. Restemeyer C, Weiller C, Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci 2007;25:143-50.
11. Goldstein L. Pharmacology of recovery after stroke. Stroke, 1990;21(11 Suppl):III139-42.
12. Hovda D, Feeney D. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 1984;298:358-61.
13. Czlonkowska A, Lesniak M. Pharmacotherapy in stroke rehabilitation. Expert Opin Pharmacother 2009;10:1249-59.
14. World Medical Association Declaration of Helsinki abttWGA, Helsinki, Finland, last amended in 2004. WMA - Ethics Unit - Declaration of Helsinki. Available from: Accessed: Jan 27, 2010.
15. Sonde L, Lokk J. Effects of amphetamine and/or L-dopa and physiotherapy after stroke-a blinded randomized study. Acta Neurol Scand 2007;115:55-9.
16. Leonard B, McCartan D, White J, King D. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 2004;19:151-80.
17. Kline A, Chen M, Tso-Olivas D, Feeney D. Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function. Pharmacol Biochem Behav 1994;48:773-9.
18. Nutl J, Fellman J. Pharmacokinetics of levodopa. Clin Neuropharmacol 1984;7:35-49.
19. Tardy J, Pariente J, Leger A et al. Methylphenidate modulates cerebral post-stroke reorganization. Neuroimage 2006;33:913-22.
20. Kempster P, Frankel J, Bovingdon M, Webster R, Lees A, Stern G. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. Br Med J 1989;52:718-23.
21. De Wit L, Kamsteegt H, Yadav B, Verheyden G, Feys H, De Weerdt W. Defining the content of individual physiotherapy and occupational therapy sessions for stroke patients in an inpatient rehabilitation setting. Development, validation and inter-rater reliability of a scoring list. Clin Rehabil 2007;21:450-9.
22. Gladstone D, Danells C, Armesto A et al. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2006;37:179-85.
23. Fugl-Meyer A, Jääskö L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med 1975;7:13-31.
24. Gladstone D, Danells C, Black S. The Fugl-Meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair 2002;16:232-40.
25. Duncan P, Propst M, Nelson S. Reliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. Phys Ther 1983;63:1606-10.
26. Collin C, Wade D, Davies S, Horne V. The Barthel ADL Index: a reliability study. Disabil Rehabil 1988;10:61-3.
27. Mahoney FI, WD B. Functional evaluation: the Barthel index. Md State Med J 1965;14:61-5.
28. Sulter G, Steen C. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538-41.
29. Fischer U, Arnold M, Nedeltchev K et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005;36:2121-5.
30. Brott T, Adams H Jr, Olinger C et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:871-5.
31. Schmulling S, Grond M, Rudolf J, Kiencke P. Training as a prerequisite for reliable use of NIH stroke scale. Stroke 1998;29:1258-9.
32. Muir K, Weir C, Murray G, Povey C, Lees K. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996;27:1817-20.
33. Hendricks H, Van Limbeek J, Geurts A, Zwarts M. Motor recovery after stroke: a systematic review of the literature. Arch Phys Med Rehabil 2002;83:1629-37.
34. Weimar C, Kurth T, Kraywinkel K et al. Assessment of functioning and disability after ischemic stroke. Stroke 2002;33:2053-9.
35. Platz T, Kim I, Engel U, Pinkowski C, Eickhof C, Kutzner M. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomised, placebo-controlled trial. Restor Neurol Neurosci 2005;23:271-80.
36. Sprigg N, Willmot M, Gray L et al. Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333). J Hum Hypertens 2007;21:616-24.
37. Treig T, Werner C, Sachse M, Hesse S. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil 2003;17:590-9.
38. Martinsson L, Eksborg S, Wahlgren N. Intensive early physiotherapy combined with dexamphetamine treatment in severe stroke: a randomized, controlled pilot study. Cerebrovasc Dis 2003;16:338-45.
39. Sonde L, Nordström M, Nilsson C, Lökk J, Viitanen M. A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis 2000;12:253-7.
40. Goldstein L. Amphetamine trials and tribulations. Stroke 2009;40:S133-5.
41. Crisostomo E, Duncan P, Propst M, Dawson D, Davis J. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988;23:94-7.
42. Sawaki L, Cohen L, Classen J, Davis B, Butefisch C. Enhancement of use-dependent plasticity by D-amphetamine. Neurology 2002;59:1262-4.
43. Feeney D. The locus coeruleus and cerebral metabolism: recovery of function after cortical injury. Physiol Psychol 1985;13:197-203.
44. Feeney D, Gonzalez A, Law W. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982;217:855-7.
45. Hovda D, Feeney D, Salo A, Boyeson M, eds. Phenoxybenzamine but not haloperidol reinstates all motor and sensory deficits in cats fully recovered from sensorimotor cortex ablations. Soc Neurosci Abstr 1983;9:1001-2.
46. Sutton RL, DM F. Alpha - noradrenergic agonists and antagonists affected recovery and maintenance of beam-walking ability after sensorimotor restor. Neurol Neurosci 1992;4:1-11.
47. Biel JH, Bopp BA. Amphetamines: structure activity relationships. In: Iverson L, Synder S, eds. Handbook of psychopharmacology. New York: Plenum Press, 1979;131.